Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

TFX Flex™ Joint Health Supplement Announces Plans to Aggressively Take on the Glucosamine & Chondroitin Market for Joint Pain Relief
  • USA - English


News provided by

TFX Health, LLC

Aug 02, 2013, 03:00 ET

Share this article

Share toX

Share this article

Share toX

TFX Flex™ Joint Health Supplement
TFX Flex™ Joint Health Supplement

This product has been shown in human clinical studies to be 2X more effective than glucosamine & chondroitin.

Post this

Salt Lake City, UT (PRWEB) August 02, 2013 -- TFX Health, LLC, a leading nutritional health and wellness company headquartered in Salt Lake City, UT announced a major marketing initiative earlier this week to take on the joint health supplement market with aggressive new online promotions aimed specifically at glucosamine & chondroitin. Since its introduction more than 2 decades ago, the combination of glucosamine and chondroitin for joint support has dominated the industry, exceeding $2 Billion in annual worldwide sales making it one of the best-selling dietary supplements in history. Despite its dominance in the industry, glucosamine & chondroitin has recently come under fire from the scientific and medical community with serious questions about the efficacy of this combination as a remedy for joint pain relief.

A study published in the British Medical Journal in 2010 concluded that, “glucosamine and chondroitin, either taken together or separately, have not shown a clinically significant improvement in joint pain relief for patients troubled with knee or hip osteoarthritis [BMJ 2010; 341:c4675]. The author of the study stated that, “Our findings indicate that glucosamine, chondroitin, and their combination do not result in a relevant improvement in joint pain relief nor affect joint space narrowing compared with placebo.”

More recently in 2012, the European Food Safety Authority (EFSA) denounced joint support claims for glucosamine. The EFSA panel concluded that, “a cause and effect relationship has not been established between the consumption of glucosamine and maintenance of normal joint cartilage in individuals with osteoarthritis” [EFSA Journal 2012;10(5):2691].

A TFX Health company spokesman explained, “The science behind joint health is rapidly changing. Glucosamine & chondroitin are no longer the only options for joint pain relief and certainly not the best option. As a company, our goal is to educate the public about better alternatives and to debunk the myth that glucosamine & chondroitin is the best remedy for joint pain.”

As part of its ongoing effort to offer better solutions, TFX Health, LLC teamed up with GNC to launch TFX Flex™ a popular new joint health supplement that is expected to revolutionize the industry. Both partners understand that joints can only be as healthy as the bones and muscles to which they are attached. TFX Flex™ is the only product on the market that combines clinically proven ingredients for muscle, bone, and joint support providing a safe and effective solution for the entire musculoskeletal system. Since its introduction, TFX Flex™ has become GNC’s best-selling triple threat for bone, muscle, and joint health.

TFX Flex™ contains a breakthrough new dietary ingredient known as UC-II® that has been proven in human clinical studies to be 2X more effective than Glucosamine & Chondroitin for joint pain relief. UC-II® was developed by a team of scientists with more than 25 years of experience in the development of patented, clinically proven dietary ingredients. It holds 7 international and U.S. patents and is supported by 9 human clinical studies, including research at Harvard Medical School.

In a randomized, double-blind, placebo-controlled human clinical study published in the International Journal of Medical Science it was found that only 40 mg of UC-II® Undenatured Type II Collagen was more than two times as effective as 1,500 mg of glucosamine and 1,200 mg of chondroitin in supporting joint health, comfort and flexibility. It outperformed the glucosamine & chondroitin combination in three different joint pain relief assessment tools: WOMAC, VAS and the Lequesne Functional Index. UC-II® significantly decreased joint pain during daily activities, including walking on a flat surface, performing heavy domestic duties, ascending stairs and while resting in bed. UC-II® was also shown to be safe and well tolerated with no known side effects [Int J Med Sci. 2009; 6:312-321].

As baby boomers age, there is a greater need for safe and effective joint health solutions. TFX Health, LLC hopes to play a leadership role in introducing these solutions to the public. Its aggressive new online marketing promotions for TFX Flex™ are designed to share this message with the world.

To learn more about TFX Flex™ Joint Health Supplement please visit http://www.TFXflex.com/

About TFX Health, LLC

Based in Salt Lake City, TFX Health, LLC is an innovative pioneer in the development of advanced health and wellness products. Its brands include TFX Flex™ Joint Health Supplement, TFX Drive™ Testosterone Booster, TFX Elite™ Extreme Thermogenic, and other high end formulations. TFX Health products are manufactured in the USA in FDA registered, GMP compliant facilities and sold worldwide through online and traditional retail channels.

UC-II® is a trademark of InterHealth N.I. Clinical data available upon request. U.S. Patents 5,645,851; 5,637,321; 5,529,786; 5,750,144; 7,083,820; 7,846,487, EPO Patent 1435906B1 and worldwide patents pending.

TFX Flex, TFX Health, LLC, http://www.TFXflex.com/, +1 (855) 735-2524, [email protected]

Modal title

TFX Flex™ Joint Health Supplement
TFX Flex™ Joint Health Supplement
Available at GNC.com
Available at GNC.com
Available at Amazon
Available at Amazon
Available at LuckyVitamin.com
Available at LuckyVitamin.com
2X More Effective Than Glucosamine & Chondroitin
2X More Effective Than Glucosamine & Chondroitin
Proudly Made in USA
Proudly Made in USA
GMP Compliant
GMP Compliant
Are You Living the TFX Lifestyle?
Are You Living the TFX Lifestyle?
TFX Flex™ Joint Health Supplement Available at GNC.com Available at Amazon Available at LuckyVitamin.com 2X More Effective Than Glucosamine & Chondroitin Proudly Made in USA GMP Compliant Are You Living the TFX Lifestyle?

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.